Home Ingredients Methylene Blue (Methylthioninium Chloride)
Cognitive

Methylene Blue (Methylthioninium Chloride)

Evidence Level
Limited
2 Clinical Trials
6 Documented Benefits
2/5 Evidence Score

Methylene blue is a SYNTHETIC SYNTHETIC PHENOTHIAZINE DYE first synthesized in 1876 — used as histological stain (1880s) and as PRESCRIPTION MEDICATION for METHEMOGLOBINEMIA, urinary tract infections (historical), and ifosfamide-induced encephalopathy. Recently popularized as 'biohacking' supplement for cognition, mitochondrial function, and longevity. CRITICAL CAUTIONS: drug-like compound with significant interactions (serotonin syndrome with SSRIs/MAOIs); can cause SEVERE TISSUE STAINING; pharmaceutical-grade vs aquarium-grade purity differences are LIFE-THREATENING; G6PD deficiency contraindication.

Studied Dose Pharmaceutical (methemoglobinemia): 1-2 mg/kg IV; 'biohacking' use: 0.5-4 mg/day oral (highly contested); CRITICAL: only PHARMACEUTICAL-GRADE / USP-GRADE methylene blue is appropriate for human consumption
Active Compound Methylene blue (methylthioninium chloride; basic blue 9; CI 52015)

Benefits

Methemoglobinemia Treatment (Established Pharmaceutical Use)

FDA-approved emergency treatment for acquired methemoglobinemia (oxidized hemoglobin can't carry oxygen). 1-2 mg/kg IV reduces methemoglobin to functional hemoglobin. Foundational legitimate medical use.

Supported by Trial 1

Ifosfamide-Induced Encephalopathy

Used to reverse encephalopathy caused by chemotherapy ifosfamide. Specific oncology indication.

Mitochondrial Function Support (Theoretical / Animal Models)

Animal studies show methylene blue supports mitochondrial electron transport chain — donates electrons to complex IV (cytochrome c oxidase). Theoretical 'mitochondrial nootropic' mechanism. Human clinical translation incomplete.

Supported by Trial 2, Trial 1

Cognitive Function (Limited Human Evidence)

trial of low-dose methylene blue (280 mg/kg) showed enhanced memory consolidation in healthy adults via fMRI. Limited rigorous trials. Most claims based on animal studies and theoretical mechanism.

Supported by Trial 1

Alzheimer's Research (Failed Trials)

TauRx Therapeutics tested methylene blue derivative LMTM (LMTX®) in Phase 3 Alzheimer's trials — FAILED to show benefit. Continues research interest. Original methylene blue not specifically approved for AD.

Supported by Trial 2, Trial 1

Antimalarial / Antimicrobial (Historical and Limited Modern)

Used historically for malaria; antimicrobial activity. Modern use limited to specific contexts.

Supported by Trial 1

Mechanism of action

1

Methemoglobin Reduction

Methylene blue is reduced to leukomethylene blue by NADPH-methemoglobin reductase; leukomethylene blue then reduces methemoglobin (Fe3+) back to hemoglobin (Fe2+). Foundational pharmaceutical mechanism.

2

Mitochondrial Electron Transport Chain Donation

At low doses, methylene blue can act as ELECTRON CARRIER between NADH and cytochrome c oxidase (complex IV) in mitochondrial ETC. Theoretical bypass of electron transport bottlenecks in stressed mitochondria. Basis for nootropic claims.

3

MAO Inhibition

Methylene blue is a POTENT MAO-A INHIBITOR — significant clinical implication for serotonin syndrome risk with serotonergic medications. Not a typical 'side effect' but core pharmacology.

4

Nitric Oxide Synthase Inhibition

Inhibits NO synthase — modulates NO/cGMP signaling. Multiple downstream effects.

5

Tau Aggregation Inhibition (Alzheimer's Mechanism)

Inhibits tau protein aggregation — basis for Alzheimer's research direction (LMTX® failed in clinical trials).

Clinical trials

1
Methylene Blue for Memory — Rodriguez 2016
PubMed

RCT of single dose methylene blue (280 mg/kg) vs placebo on memory tasks with fMRI in 26 healthy adults.

26 healthy adults.

Improved memory retrieval and increased fMRI activity in memory-related brain areas. Single dose; small sample; generated continued research interest.

2
LMTM (Methylene Blue Derivative) for Alzheimer's — Gauthier 2016
PubMed

Phase 3 RCT of LMTM (200 mg/day) vs placebo monotherapy or as add-on in Alzheimer's patients.

Alzheimer's patients.

FAILED to show benefit on primary outcomes. Significant disappointment for tau-targeting Alzheimer's strategy. Generated questions about methylene blue derivatives' clinical utility.

Side effects and drug interactions

Common Potential side effects

BLUE/GREEN URINE — universal (harmless but striking).
Tissue staining (skin, mucous membranes, surgical fields).
GI distress (nausea, vomiting).
Headache, dizziness.
Hypertension at higher doses.
SEROTONIN SYNDROME with serotonergic medications — POTENTIALLY FATAL.
Hemolytic anemia in G6PD deficiency.
Methemoglobinemia paradoxically at high doses.
Confusion, anxiety.
Skin rash.

Important Drug interactions

SEROTONERGIC MEDICATIONS — POTENTIALLY FATAL serotonin syndrome:
SSRIs (fluoxetine, sertraline, paroxetine, citalopram, escitalopram, fluvoxamine).
SNRIs (venlafaxine, duloxetine, desvenlafaxine).
TCAs (amitriptyline, nortriptyline, imipramine).
MAOIs (selegiline, rasagiline, phenelzine, tranylcypromine, isocarboxazid).
TRIPTANS (sumatriptan, rizatriptan, etc.).
TRAMADOL, MEPERIDINE, FENTANYL.
ST. JOHN'S WORT.
LITHIUM, BUSPIRONE, TRAZODONE.
MDMA, COCAINE.
These combinations require WASHOUT periods (typically 5-6 weeks for fluoxetine, 2 weeks for most SSRIs).
G6PD DEFICIENCY — CONTRAINDICATED.
Pregnancy — AVOID (multiple concerns).
Lactation — AVOID.
Anesthesia — significant interactions; disclose use to anesthesiologist.

More Cognitive Ingredients

Energy
Caffeine
Caffeine, a natural stimulant found in coffee, tea, and other plants, is commonly suppleme…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cognitive
Vitamin B12
Vitamin B12, also known as cobalamin, is a water-soluble vitamin commonly supplemented as…
Immune Support
Zinc
Zinc, an essential trace mineral, is commonly supplemented in forms like zinc gluconate, a…

Frequently asked questions about Methylene Blue (Methylthioninium Chloride)

What is Methylene Blue (Methylthioninium Chloride)?

Methylene blue is a SYNTHETIC SYNTHETIC PHENOTHIAZINE DYE first synthesized in 1876 — used as histological stain (1880s) and as PRESCRIPTION MEDICATION for METHEMOGLOBINEMIA, urinary tract infections (historical), and ifosfamide-induced encephalopathy.

What does Methylene Blue (Methylthioninium Chloride) do?

Methylene blue is reduced to leukomethylene blue by NADPH-methemoglobin reductase; leukomethylene blue then reduces methemoglobin (Fe3+) back to hemoglobin (Fe2+). Foundational pharmaceutical mechanism. In clinical research, Methylene Blue (Methylthioninium Chloride) has been studied for methemoglobinemia treatment (established pharmaceutical use), ifosfamide-induced encephalopathy, mitochondrial function support (theoretical / animal models).

Who should take Methylene Blue (Methylthioninium Chloride)?

Methylene Blue (Methylthioninium Chloride) may be most relevant for people interested in cognitive. It has been clinically studied for methemoglobinemia treatment (established pharmaceutical use), ifosfamide-induced encephalopathy, mitochondrial function support (theoretical / animal models). As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Methylene Blue (Methylthioninium Chloride) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Methylene Blue (Methylthioninium Chloride)?

For cognitive goals, Methylene Blue (Methylthioninium Chloride) is typically taken in the morning with breakfast for sustained daytime effects. Avoid late-day dosing if it affects your sleep. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Methylene Blue (Methylthioninium Chloride) worth taking?

Methylene Blue (Methylthioninium Chloride) has limited clinical evidence (Evidence Level 2/5 on NutraSmarts) — preliminary research suggests potential benefit, but more rigorous trials are needed. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Methylene Blue (Methylthioninium Chloride) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Methylene Blue (Methylthioninium Chloride)?

The clinically studied dose for Methylene Blue (Methylthioninium Chloride) is Pharmaceutical (methemoglobinemia): 1-2 mg/kg IV; 'biohacking' use: 0.5-4 mg/day oral (highly contested); CRITICAL: only PHARMACEUTICAL-GRADE / USP-GRADE methylene blue is appropriate for human consumption. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Methylene Blue (Methylthioninium Chloride) used for?

Methylene Blue (Methylthioninium Chloride) is studied for methemoglobinemia treatment (established pharmaceutical use), ifosfamide-induced encephalopathy, mitochondrial function support (theoretical / animal models). FDA-approved emergency treatment for acquired methemoglobinemia (oxidized hemoglobin can't carry oxygen). 1-2 mg/kg IV reduces methemoglobin to functional hemoglobin. Foundational legitimate medical use.